IQUIX® 1.5% Prescription Eye Drops

Introducing IQUIX® 1.5%
Prescription Eye Drops

New IQUIX® 1.5% - Delivering powerful concentration above and below the ocular surface to give you power where you need it. Take concentration to a new level.

High Sustained Concentrations
Rapidly achieves and sustains high concentrations in tears.

Penetrates human corneal tissue and aqueous humor to concentrations that exceed MIC90 values of common ocular pathogens

High Concentration and Coverage
Broad coverage of gram-negative and gram-positive pathogens, including P. aeruginosa, S. marcescens, S. aureus, S. epidermidis, and S. pneumoniae

Ocular T.R.U.S.T. surveillance data documents high susceptibility of key ocular pathogens (2006-2007)

Dual mechanism of action similar to gatifloxacin and moxifloxacin

Well-Tolerated Concentration
Low cytotoxicity to both human corneal endothelial cells and keratocytes.

Preservative-free, near neutral pH formulation.

To Download IQUIX® Image:
Right Click on the IQUIX® image to the Left.

Select "Save Picture As".

IQUIX® is a registered trademark of Daiichi-Sankyo Co. Ltd., Tokyo, Japan
Manufactured by Santen Oy, Tampere, Finland, and marketed by VISTAKON® Pharmaceuticals, LLC.

VISTAKON® is a registered trademark of VISTAKON® Pharmaceuticals, LLC.